Accessibility Menu
 
Proteome Sciences Plc logo

Proteome Sciences Plc

(LSE) PRM

Current Price$1.56
Market Cap$554.15M
Since IPO (1995)-99%
5 Year-61%
1 Year-61%
1 Month-10%

Proteome Sciences Plc Financials at a Glance

Market Cap

$554.15M

Revenue (TTM)

$8.56M

Net Income (TTM)

$7.41M

EPS (TTM)

$-1.13

P/E Ratio

-1.40

Dividend

$0.00

Beta (Volatility)

-0.06 (Low)

Price

$1.56

Volume

63,643

Open

$1.60

Previous Close

$1.56

Daily Range

$1.56 - $1.60

52-Week Range

$1.30 - $4.40

PRM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Proteome Sciences Plc

Industry

Life Sciences Tools and Services

CEO

Mariola Söhngen, MD

Headquarters

Cobham, KT11 3EP, GB

PRM Financials

Key Financial Metrics (TTM)

Gross Margin

-1%

Operating Margin

-50%

Net Income Margin

-74%

Return on Equity

0%

Return on Capital

31%

Return on Assets

-40%

Earnings Yield

-71.43%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$554.15M

Shares Outstanding

350.73M

Volume

63.64K

Short Interest

0.00%

Avg. Volume

393.08K

Financials (TTM)

Gross Profit

$167.00K

Operating Income

$2.27M

EBITDA

$1.44M

Operating Cash Flow

$826.00K

Capital Expenditure

$224.00K

Free Cash Flow

$1.05M

Cash & ST Invst.

$1.13M

Total Debt

$14.52M

Proteome Sciences Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$1.86M

-42.1%

Gross Profit

$90.00K

-105.1%

Gross Margin

-4.85%

N/A

Market Cap

$554.15M

N/A

Market Cap/Employee

$15.39M

N/A

Employees

36

N/A

Net Income

$2.14M

-270.2%

EBITDA

$1.21M

-1066.4%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$15.13M

-101.7%

Accounts Receivable

$947.00K

-15.7%

Inventory

$491.00K

-46.2%

Long Term Debt

$845.00K

+328.9%

Short Term Debt

$14.55M

+31.2%

Return on Assets

-39.94%

N/A

Return on Invested Capital

31.14%

N/A

Free Cash Flow

$955.00K

-100.0%

Operating Cash Flow

$897.00K

-100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FDBK.LFeedback plc
$12.75-1.92%
GDR.LGenedrive Plc
$0.95+0.00%
TRX.LTissue Regenix Group plc
$7.25+0.00%
MHC.LMyHealthChecked PLC
$8.75-2.78%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NOKNokia
$8.82+0.07%

Questions About PRM

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.